Published Date: 06 Nov 2023
Researchers at Brigham and Women's Hospital discovered this in a recent study after doing a meta-analysis of five prospective randomized clinical trials (RCTs).
Read Full NewsEurope will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.
Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.
Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.
MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.
Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.
1.
FDA Panel Endorses Capivasertib Use in Prostate Cancer
2.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
3.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
4.
MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy
5.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
1.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
2.
The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025
3.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
4.
Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part XV
2.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation